Researchers examine the use of antiretroviral therapy among injection drug users with HIV infection: Study suggests addiction treatment and health care contribute to HAART enrollment

Over 40 percent of injection drug users with HIV that are eligible for the highly active antiretroviral therapy (HAART) fail to undergo the treatment, according to a study conducted by the Johns Hopkins Bloomberg School of Public Health.

The HAART regimen, or "drug cocktail," is a combination of several antiretroviral drugs that can dramatically reduce the levels of HIV in the body and slow the progression to AIDS. The study, which appears in the September 2001 issue of the journal, AIDS, suggests that injection drug use is a major impediment to initiating HAART therapy, while methadone addiction treatment among men, health insurance, and access to regular health care were factors associated with increased HAART use.

"Injection drug users directly or indirectly account for nearly half of all the people infected with HIV in the United States each year, and they are a population that could certainly benefit from HAART use.

In addition to making people with HIV feel better, HAART has also been shown to make them less infectious to others by reducing their viral load, so there is a real benefit to the public," says lead author David D. Celentano, ScD, MHS, professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health.

"Over the years, we've seen an increase in the number of injection drug users undergoing HAART, but a large number still do not use the therapy. It is important to understand the factors involved in why drug users choose or do not choose this therapy. Our study examines some of the factors that contribute to HAART use among injection drug users with HIV," adds Dr. Celentano.

For the study, researchers examined 528 HIV-infected injection drug users living in Baltimore, Maryland between 1996 and 1999. All of the study's participants were originally part of a larger long-term study of AIDS and injection drug users known as AIDS Links to Intravenous Experience (ALIVE). In addition, all of the partic

Contact: Tim Parsons or Ming Tai
Johns Hopkins University Bloomberg School of Public Health

Page: 1 2

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
8. Researchers offer emergency workers a lifeline
9. Researchers discover genetic variant that may explain why women develop M.S. more than men
10. Researchers map the sexual network of an entire high school
11. Researchers hope monkeys can provide new insights into depression

Post Your Comments:

(Date:5/14/2019)... ... May 14, 2019 , ... Impact Advisors, a ... industry, announced today that John Stanley, Vice President, has been named one of ... for the Western U.S., has been recognized in the Excellence in Healthcare category. ...
(Date:5/14/2019)... ... 14, 2019 , ... A high number of HIV cases among the LGBTQ ... the Houston area and the southern United States. Specifically, the sub-groups at greater ... with men (MSM) and transgender people of color ages 13 to 34. In ...
(Date:5/14/2019)... ... May 14, 2019 , ... Relatient, Inc., a leader in ... Check-In solution , a new product launched to reduce patient wait times and ... Relatient’s Patient Engagement platform introducing earlier touch points on the patient journey ...
(Date:5/14/2019)... ... May 14, 2019 , ... Forty-two billion dollars ... and procedures, according to market analysis company Orbis Research. “Treatments certainly can help,” ... Advanced Dermatology PC , “but for our skin, there’s free super-potent anti-aging care ...
(Date:5/14/2019)... ... 2019 , ... Dr. Steven Shoshany has been treating patients experiencing both acute ... cold laser therapy device, becoming the first chiropractor in Manhattan to do so. Since ... FDA clearances for treating pain and injuries, into his downtown practice. He recently finished ...
Breaking Medicine News(10 mins):
(Date:5/16/2019)... NEW YORK (PRWEB) , ... May 16, 2019 ... ... digital health platform and portfolio company of Topspin Partners, today announced the acquisition ... in the diabetes, mental health, back pain, and pain management areas. This acquisition ...
(Date:5/16/2019)... ... May 16, 2019 , ... Luma Health https://www.lumahealth.io/ ... Patient Intake. This new solution helps providers deliver a top-notch patient experience by ... on their device of choice, days or weeks prior to their appointment. By ...
(Date:5/15/2019)... ... May 15, 2019 , ... Claudius ... network’s new Vice President of Information Technology. Over the last 15 years, Moore ... for healthcare systems, while also creating a high-quality, efficient experience for patients. , ...
Breaking Medicine Technology:
Cached News: